Gynecologic Cancer

Top Story

Edoxaban noninferior to warfarin for cancer, VTE

July 29, 2016

Edoxaban may more effectively treat venous thromboembolism and produce less clinically relevant bleeding than warfarin in patients with cancer, according to a subgroup analysis of a randomized, double blind, double-dummy, open-label trial.

VTE is a common adverse event in patients with cancer. Direct oral anticoagulants, such as edoxaban (Savaysa, Daiichi Sankyo), have been proven noninferior to conventional anticoagulation treatments.

In the Journals Plus

Ovarian cancer surveillance with CA-125 tests, CT scans common despite lack of proven benefit

July 29, 2016
Cancer antigen 125 tests and CT scans are routinely used for surveillance of patients with ovarian cancer despite a lack of proven benefit, according to results of a…
In the Journals Plus

Opinions on prognosis often discordant between patients and their oncologists

July 27, 2016
Patients with advanced cancers frequently interpreted their prognoses differently from their oncologists, according to the results of a cross-sectional study published…
In the Journals Plus

Second malignancies, death common among cancer survivors

July 25, 2016
Approximately one in 12 patients with a common primary tumor were diagnosed with a second primary malignancy between 1992 and 2008, according to results of a SEER…
CME

The Patient with Lymphadenopathy

No commercial support for this activity.

Castleman’s disease is a rare lymphoproliferative disorder that is characterized by enlargement of 1 (unicentric) or…
More »
Video
Meeting News Coverage

VIDEO: HPV vaccination trial provides 'reassuring' data on multisite protection

April 28, 2015
More »
Featured
2016 ASCO Annual Meeting

2016 ASCO Annual Meeting

CME

The Patient with Castration-resistant Prostate Cancer

No commercial support for this activity.

Castration-resistant prostate cancer (CRPC) is a heterogeneous condition that encompasses a continuum of disease…
More »
In the Journals Plus

Edoxaban noninferior to warfarin for cancer, VTE

July 29, 2016
Edoxaban may more effectively treat venous thromboembolism and produce less clinically relevant bleeding than warfarin in patients with cancer…

In the Journals Plus

Ovarian cancer surveillance with CA-125 tests, CT scans common despite lack of proven benefit

July 29, 2016
Cancer antigen 125 tests and CT scans are routinely used for surveillance of patients with ovarian cancer despite a lack of proven benefit, according…

In the Journals Plus

Opinions on prognosis often discordant between patients and their oncologists

July 27, 2016
Patients with advanced cancers frequently interpreted their prognoses differently from their oncologists, according to the results of a…

In the Journals Plus

Second malignancies, death common among cancer survivors

July 25, 2016
Approximately one in 12 patients with a common primary tumor were diagnosed with a second primary malignancy between 1992 and 2008, according to…

In the Journals Plus

Delirium frequently underdiagnosed in patients with advanced cancers

July 25, 2016
Delirium occurs frequently but appears underdiagnosed in patients with advanced cancer who presented in the ED, according to the results of a…

What cancer screenings are recommended for women?

July 22, 2016
Women have a 37% chance of developing invasive cancer during their lifetime, and a 19% chance of dying of cancer, according to American Cancer…

FDA News

FDA grants AXAL fast track designation to treat cervical cancer

July 21, 2016
The FDA granted fast track designation to axalimogene filolisbac for the adjuvant treatment of high-risk locally advanced cervical cancer. The…

American Cancer Society endorses CDC’s HPV vaccine recommendations

July 20, 2016
The American Cancer Society endorsed a CDC advisory committee recommendation that all children ages 11 to 12 years old receive HPV vaccination…

FDA News

FDA grants CRLX101 fast track designation to treat ovarian cancer

July 19, 2016
The FDA granted fast track designation to CRLX101 in combination with paclitaxel for the treatment of platinum-resistant ovarian carcinoma, fallopian…

In the Journals

Ovarian reserves lower in BRCA1 mutation carriers

July 18, 2016
Women with mutations in the BRCA1 gene may have fewer eggs than women who do not have the mutation, according to results of a cross-sectional study…

More Headlines »
morganatic-roan
morganatic-roan